Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ergomed Makes Board Changes

This article was originally published in Scrip

Executive Summary

Ergomed Plc. has appointed current chief financial officer (CFO), Neil Clark, as fulltime CEO of the company's trading subsidiary PrimeVigilance. Neil will remain on Ergomed's board of directors and Stephen Stamp, who has been appointed as the company's CFO, will also be joining its board. Stamp has over 30 years' experience in corporate finance and general management and joins Ergomed from US-based AssureRx Health, Inc., where he was CFO. Before this, he was CFO of EZCORP, Inc., and chief operating officer and CFO of Xanodyne Pharmaceuticals, Inc. Stamp was also group finance director at Regus Plc. and prior to this he held the same position at Shire Pharmaceuticals.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC064250

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel